Mesothelioma is a rare and aggressive cancer deriving by uncontrolled growth of mesothelial cells and is most commonly caused by exposure to asbestos. The most common site for mesothelioma is the pleura (outer lining of the lungs), but it can also arise in the abdominal (peritoneum) or cardiac...
Hello and welcome to our comprehensive journal article on clinical trials for mesothelioma. This deadly cancer has challenged the medical community for decades, causing devastating effects on patients and their families. However, recent advancements in treatments have led to new clinical trials that may...
Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma. Cancer Biol. Ther. 2018, 19, 316–327. [Google Scholar] [CrossRef] [Green Version] Massó-Vallés, D.; Jauset, T.; Serrano, E.; Sodir, N.M.; Pedersen, K.; Affara, N.I.;...
Discover the latest mesothelioma news on covering treatments, clinical trials, cancer doctors, asbestos exposure and legislation to ban asbestos.
Scientists create a world-first 3D cell model to help develop treatments for devastating lip injuries We use our lips to talk, eat, drink, and breathe; they signal our emotions, health, and aesthetic beauty. It takes a complex structure to perform so many roles, so lip problems can be har...
“Mind-body exercise offers a low-cost approach that could be used as a complement to traditional psychotherapy or drug treatments,” said the study’s lead author, Sang H. Kim, PhD, of the National Institutes of Health. “These self-directed practices give PTSD patients control over their ...
Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma. Cancer Biol. Ther. 2018, 19, 316–327. [CrossRef] 151. Massó-Vallés, D.; Jauset, T.; Serrano, E.; Sodir, N.M.; Pedersen, K.; Affara, N.I.; Whitfield, J.R.; ...